81_FR_76586 81 FR 76374 - National Institute of Allergy And Infectious Diseases; Notice of Closed Meeting

81 FR 76374 - National Institute of Allergy And Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 212 (November 2, 2016)

Page Range76374-76375
FR Document2016-26388

Federal Register, Volume 81 Issue 212 (Wednesday, November 2, 2016) 
[Federal Register Volume 81, Number 212 (Wednesday, November 2, 2016)]
[Notices]
[Pages 76374-76375]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-26388]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy And Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Division of Intramural Research Board of Scientific Counselors, NIAID.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Allergy and Infectious Diseases, including consideration 
of personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Division of Intramural Research Board of 
Scientific Counselors, NIAID.
    Date: December 12-14, 2016.
    Time: December 12, 2016, 7:45 a.m. to 5:45 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 50, Louis Stokes 
Laboratories, Conference Rooms 1227/1233, 50 Center Drive, Bethesda, 
MD 20892.

    Time: December 13, 2016, 7:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 50, Louis Stokes 
Laboratories, Conference Rooms 1227/1233, 50 Center Drive, Bethesda, 
MD 20892.

    Time: December 14, 2016, 7:00 a.m. to Adjournment.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 50, Louis Stokes 
Laboratories, Conference Rooms 1227/1233, 50 Center Drive, Bethesda, 
MD 20892.

    Contact Person: Steven M. Holland, MD, Ph.D., Chief, Laboratory 
of Clinical Infectious Diseases, National Institutes of Health/
NIAID, Hatfield Clinical Research Center, Bethesda, MD 20892-1684, 
301-402-7684, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 76375]]


    Dated: October 26, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-26388 Filed 11-1-16; 8:45 am]
 BILLING CODE 4140-01-P

76374 Federal Register / Vol. 81, No. 212 / Wednesday, November 2, 2016 / Notices Time: 8:00 a.m. to 6:00 p.m. provisions set forth in sections DEPARTMENT OF HEALTH AND Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., HUMAN SERVICES applications. as amended. The grant applications and Place: National Institutes of Health, 6701 National Institutes of Health Rockledge Drive, Bethesda, MD 20892 the discussions could disclose (Virtual Meeting). confidential trade secrets or commercial National Institute of Allergy And Contact Person: Elena Smirnova, Ph.D., property such as patentable material, Scientific Review Officer, Center for Infectious Diseases; Notice of Closed and personal information concerning Meeting Scientific Review, National Institutes of individuals associated with the grant Health, 6701 Rockledge Drive, Room 5187, Pursuant to section 10(d) of the MSC 7840, Bethesda, MD 20892, 301–435– applications, the disclosure of which 1236, smirnove@csr.nih.gov. would constitute a clearly unwarranted Federal Advisory Committee Act, as invasion of personal privacy. amended (5 U.S.C. App.), notice is Name of Committee: Center for Scientific Review Special Emphasis Panel; Member hereby given of a meeting of the Name of Committee: National Institute of Conflict: Molecular and Cellular Aspects of Division of Intramural Research Board Child Health and Human Development Nutrition, Obesity and Diabetes. of Scientific Counselors, NIAID. Special Emphasis Panel. The meeting will be closed to the Date: November 29, 2016. Time: 10:00 a.m. to 6:00 p.m. Date: November 4, 2016. public as indicated below in accordance Agenda: To review and evaluate grant Time: 8:00 a.m. to 5:00 p.m. with the provisions set forth in section applications. Agenda: To review and evaluate grant 552b(c)(6), Title 5 U.S.C., as amended Place: National Institutes of Health, 6701 applications. for the review, discussion, and Rockledge Drive, Bethesda, MD 20892 Place: Residence Inn Bethesda, 7335 (Virtual Meeting). evaluation of individual intramural Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Raul Rojas, Ph.D., programs and projects conducted by the Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review Officer, Scientific Review National Institute of Allergy and Scientific Review Officer, Division of Officer, Center for Scientific Review, 6701 Scientific Review, OD, Eunice Kennedy Infectious Diseases, including Rockledge Drive, Room 6185, Bethesda, MD consideration of personnel 20892, (301)451–6319, rojasr@mail.nih.gov. Shriver National Institute of Child Health and Human Development, NIH, DHHS, qualifications and performance, and the Name of Committee: Center for Scientific competence of individual investigators, Review Special Emphasis Panel; PAR–12– 6710B Rockledge Drive, Bethesda, MD 20892, 301–435–6878, wedeenc@mail.nih.gov. the disclosure of which would 251: Behavioral Science Track Award for constitute a clearly unwarranted Rapid Transition Review. This notice is being published less than 15 Date: December 2, 2016. invasion of personal privacy. days prior to the meeting due to the timing Time: 1:30 p.m. to 4:00 p.m. limitations imposed by the review and Name of Committee: Division of Intramural Agenda: To review and evaluate grant funding cycle. Research Board of Scientific Counselors, applications. NIAID. Place: National Institutes of Health, 6701 Name of Committee: National Institute of Date: December 12–14, 2016. Rockledge Drive, Bethesda, MD 20892 Child Health and Human Development Time: December 12, 2016, 7:45 a.m. to 5:45 (Telephone Conference Call). Special Emphasis Panel; Multivariate p.m. Contact Person: Wind Cowles, Ph.D., Genetics & Genomics of Reading & Agenda: To review and evaluate personal Scientific Review Officer, Center for Comprehension & Related Cognition. qualifications and performance, and Scientific Review, National Institutes of Date: November 28, 2016. competence of individual investigators. Health, 6701 Rockledge Drive, Room 3172, Time: 1:00 p.m. to 4:00 p.m. Place: National Institutes of Health, Bethesda, MD 20892, cowleshw@csr.nih.gov. Agenda: To review and evaluate grant Building 50, Louis Stokes Laboratories, (Catalogue of Federal Domestic Assistance Conference Rooms 1227/1233, 50 Center applications. Program Nos. 93.306, Comparative Medicine; Drive, Bethesda, MD 20892. Place: National Institutes of Health, 6710 B 93.333, Clinical Research, 93.306, 93.333, Time: December 13, 2016, 7:30 a.m. to 5:00 Rockledge Drive, Bethesda, MD 20892, 93.337, 93.393–93.396, 93.837–93.844, p.m. 93.846–93.878, 93.892, 93.893, National (Telephone Conference Call). Agenda: To review and evaluate personal Institutes of Health, HHS) Contact Person: Marita R. Hopmann, Ph.D., qualifications and performance, and Scientific Review Officer, Division of competence of individual investigators. Dated: October 27, 2016. Scientific Review, National Institute of Child Place: National Institutes of Health, Carolyn Baum, Health and Human Development, 6710B Building 50, Louis Stokes Laboratories, Program Analyst, Office of Federal Advisory Rockledge Drive, Bethesda, MD 20892, (301) Conference Rooms 1227/1233, 50 Center Committee Policy. 435–6911, hopmannm@mail.nih.gov. Drive, Bethesda, MD 20892. [FR Doc. 2016–26454 Filed 11–1–16; 8:45 am] Time: December 14, 2016, 7:00 a.m. to (Catalogue of Federal Domestic Assistance BILLING CODE 4140–01–P Program Nos. 93.864, Population Research; Adjournment. 93.865, Research for Mothers and Children; Agenda: To review and evaluate personal 93.929, Center for Medical Rehabilitation qualifications and performance, and DEPARTMENT OF HEALTH AND competence of individual investigators. Research; 93.209, Contraception and HUMAN SERVICES Place: National Institutes of Health, Infertility Loan Repayment Program, National Building 50, Louis Stokes Laboratories, Institutes of Health, HHS) Conference Rooms 1227/1233, 50 Center National Institutes of Health Dated: October 27, 2016. Drive, Bethesda, MD 20892. Eunice Kennedy Shriver National Michelle Trout, Contact Person: Steven M. Holland, MD, Institute Of Child Health & Human Ph.D., Chief, Laboratory of Clinical Infectious Program Analyst, Office of Federal Advisory Diseases, National Institutes of Health/ Development; Notice of Closed sradovich on DSK3GMQ082PROD with NOTICES Committee Policy. NIAID, Hatfield Clinical Research Center, Meetings [FR Doc. 2016–26387 Filed 11–1–16; 8:45 am] Bethesda, MD 20892–1684, 301–402–7684, Pursuant to section 10(d) of the BILLING CODE 4140–01–P sholland@mail.nih.gov. Federal Advisory Committee Act, as (Catalogue of Federal Domestic Assistance amended (5 U.S.C. App.), notice is Program Nos. 93.855, Allergy, Immunology, hereby given of the following meetings. and Transplantation Research; 93.856, The meetings will be closed to the Microbiology and Infectious Diseases public in accordance with the Research, National Institutes of Health, HHS) VerDate Sep<11>2014 17:18 Nov 01, 2016 Jkt 241001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\02NON1.SGM 02NON1

Federal Register / Vol. 81, No. 212 / Wednesday, November 2, 2016 / Notices 76375 Dated: October 26, 2016. Order 12564 and section 503 of Public Clinical Reference Laboratory, Inc., 8433 Natasha M. Copeland, Law 100–71. The ‘‘Mandatory Quivira Road, Lenexa, KS 66215– Program Analyst, Office of Federal Advisory Guidelines for Federal Workplace Drug 2802, 800–445–6917. Committee Policy. Testing Programs,’’ as amended in the DrugScan, Inc., 200 Precision Road, [FR Doc. 2016–26388 Filed 11–1–16; 8:45 am] revisions listed above, requires strict Suite 200, Horsham, PA 19044, 800– BILLING CODE 4140–01–P standards that laboratories and IITFs 235–4890. must meet in order to conduct drug and Dynacare*, 245 Pall Mall Street, specimen validity tests on urine London, ONT, Canada N6A 1P4, 519– DEPARTMENT OF HEALTH AND specimens for federal agencies. 679–1630, (Formerly: Gamma- HUMAN SERVICES To become certified, an applicant Dynacare Medical Laboratories). laboratory or IITF must undergo three ElSohly Laboratories, Inc., 5 Industrial Substance Abuse and Mental Health rounds of performance testing plus an Park Drive, Oxford, MS 38655, 662– Services Administration on-site inspection. To maintain that 236–2609. certification, a laboratory or IITF must Fortes Laboratories, Inc., 25749 SW. Current List of HHS-Certified participate in a quarterly performance Canyon Creek Road, Suite 600, Laboratories and Instrumented Initial testing program plus undergo periodic, Wilsonville, OR 97070, 503–486– Testing Facilities Which Meet Minimum on-site inspections. 1023. Standards To Engage in Urine Drug Laboratory Corporation of America Laboratories and IITFs in the Testing for Federal Agencies Holdings, 7207 N. Gessner Road, applicant stage of certification are not to be considered as meeting the minimum Houston, TX 77040, 713–856–8288/ AGENCY: Substance Abuse and Mental requirements described in the HHS 800–800–2387. Health Services Administration, HHS. Laboratory Corporation of America ACTION: Notice. Mandatory Guidelines. A HHS-certified Holdings, 69 First Ave., Raritan, NJ laboratory or IITF must have its letter of SUMMARY: The Department of Health and 08869, 908–526–2400/800–437–4986, certification from HHS/SAMHSA Human Services (HHS) notifies federal (Formerly: Roche Biomedical (formerly: HHS/NIDA), which attests agencies of the laboratories and Laboratories, Inc.). that it has met minimum standards. Instrumented Initial Testing Facilities Laboratory Corporation of America In accordance with the Mandatory Holdings, 1904 Alexander Drive, (IITF) currently certified to meet the Guidelines dated November 25, 2008 standards of the Mandatory Guidelines Research Triangle Park, NC 27709, (73 FR 71858), the following HHS- 919–572–6900/800–833–3984, for Federal Workplace Drug Testing certified laboratories and IITFs meet the Programs (Mandatory Guidelines). The (Formerly: LabCorp Occupational minimum standards to conduct drug Testing Services, Inc., CompuChem Mandatory Guidelines were first and specimen validity tests on urine published in the Federal Register on Laboratories, Inc.; CompuChem specimens: Laboratories, Inc., A Subsidiary of April 11, 1988 (53 FR 11970), and subsequently revised in the Federal HHS-Certified Instrumented Initial Roche Biomedical Laboratory; Roche Register on June 9, 1994 (59 FR 29908); Testing Facilities CompuChem Laboratories, Inc., A September 30, 1997 (62 FR 51118); Member of the Roche Group). Dynacare, 6628 50th Street NW., Laboratory Corporation of America April 13, 2004 (69 FR 19644); November Edmonton, AB Canada T6B 2N7, 780– 25, 2008 (73 FR 71858); December 10, Holdings, 1120 Main Street, 784–1190, (Formerly: Gamma- Southaven, MS 38671, 866–827–8042/ 2008 (73 FR 75122); and on April 30, Dynacare Medical Laboratories). 2010 (75 FR 22809). 800–233–6339, (Formerly: LabCorp A notice listing all currently HHS- HHS-Certified Laboratories Occupational Testing Services, Inc.; certified laboratories and IITFs is MedExpress/National Laboratory ACM Medical Laboratory, Inc., 160 published in the Federal Register Center). Elmgrove Park, Rochester, NY 14624, LabOne, Inc. d/b/a Quest Diagnostics, during the first week of each month. If 585–429–2264. any laboratory or IITF certification is 10101 Renner Blvd., Lenexa, KS Aegis Analytical Laboratories, Inc., 345 66219, 913–888–3927/800–873–8845, suspended or revoked, the laboratory or Hill Ave., Nashville, TN 37210, 615– IITF will be omitted from subsequent (Formerly: Quest Diagnostics 255–2400, (Formerly: Aegis Sciences Incorporated; LabOne, Inc.; Center for lists until such time as it is restored to Corporation, Aegis Analytical full certification under the Mandatory Laboratory Services, a Division of Laboratories, Inc., Aegis Analytical LabOne, Inc.). Guidelines. Laboratories). If any laboratory or IITF has MedTox Laboratories, Inc., 402 W. Alere Toxicology Services, 1111 Newton County Road D, St. Paul, MN 55112, withdrawn from the HHS National St., Gretna, LA 70053, 504–361–8989/ Laboratory Certification Program (NLCP) 651–636–7466/800–832–3244. 800–433–3823, (Formerly: Kroll MetroLab-Legacy Laboratory Services, during the past month, it will be listed Laboratory Specialists, Inc., 1225 NE 2nd Ave., Portland, OR at the end and will be omitted from the Laboratory Specialists, Inc.). 97232, 503–413–5295/800–950–5295. monthly listing thereafter. Alere Toxicology Services, 450 This notice is also available on the Minneapolis Veterans Affairs Medical Southlake Blvd., Richmond, VA Center, Forensic Toxicology Internet at http://www.samhsa.gov/ 23236, 804–378–9130, (Formerly: workplace. Laboratory, 1 Veterans Drive, Kroll Laboratory Specialists, Inc., Minneapolis, MN 55417, 612–725– FOR FURTHER INFORMATION CONTACT: Scientific Testing Laboratories, Inc.; sradovich on DSK3GMQ082PROD with NOTICES 2088, Testing for Veterans Affairs Giselle Hersh, Division of Workplace Kroll Scientific Testing Laboratories, (VA) Employees Only. Programs, SAMHSA/CSAP, 5600 Inc.). National Toxicology Laboratories, Inc., Fishers Lane, Room 16N03A, Rockville, Baptist Medical Center-Toxicology 1100 California Ave., Bakersfield, CA Maryland 20857; 240–276–2600 (voice). Laboratory, 11401 I–30, Little Rock, 93304, 661–322–4250/800–350–3515. SUPPLEMENTARY INFORMATION: The AR 72209–7056, 501–202–2783, One Source Toxicology Laboratory, Inc., Mandatory Guidelines were initially (Formerly: Forensic Toxicology 1213 Genoa-Red Bluff, Pasadena, TX developed in accordance with Executive Laboratory Baptist Medical Center). 77504, 888–747–3774, (Formerly: VerDate Sep<11>2014 17:18 Nov 01, 2016 Jkt 241001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\02NON1.SGM 02NON1


Document Created: 2016-11-02 01:40:36
Document Modified: 2016-11-02 01:40:36
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesDecember 12-14, 2016.
FR Citation81 FR 76374 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR